@article{ART001590402},
author={PARK JAE HYUN and Cheong Yooseok},
title={Physician-industry Relationships in Continuing Medical Education},
journal={Korean Journal of Medical Ethics },
issn={2005-8284},
year={2011},
volume={14},
number={3},
pages={335-342},
doi={10.35301/ksme.2011.14.3.335}
TY - JOUR
AU - PARK JAE HYUN
AU - Cheong Yooseok
TI - Physician-industry Relationships in Continuing Medical Education
JO - Korean Journal of Medical Ethics
PY - 2011
VL - 14
IS - 3
PB - The Korean Society For Medical Ethics
SP - 335
EP - 342
SN - 2005-8284
AB - Physicians have both an ethical obligation and a right to participate in continuing medical education (CME) programs to constantly maintain and upgrade their knowledge and skills after the completion of their formal education. CME is the pharmaceutical industry’s most important marketing tool. CME is increasingly being funded by the pharmaceutical industry; currently the financial support from drug and device companies accounts for up to 60% of the costs of all accredited CME programs in the U.S. CME requirements for Korean physicians are somewhat lax at the present time, but industry sponsored CME is on the rise in Korea. With the increase in industry funded CME, there is cause for concern about potential conflicts of interest, scientific biases, and the educational quality of industry-funded CME. Physicians’ reliance on industry-funded CME has the potential to influence negatively their clinical decisions and to increase spending on prescription drugs. For these reasons, a growing number of medical institutions in the U.S. have limited or phased-out industry sponsorship of CME at their institutions. This article argues that in order to ensure the professional integrity of physicians and the process of learning in CME, physicians and pharmaceutical industries need more explicit codes of conduct and guidelines. Individual doctors should recognize the potential for the industry to influence their prescribing habits and follow the ethical principles of physician-industry relationships. Also, in order to better balance learning needs and patient concerns, physicians should have the information and skills required to make informed decisions in CME.
KW - continuing medical education;physician-pharmaceutical industry interaction;ethical relationship
DO - 10.35301/ksme.2011.14.3.335
ER -
PARK JAE HYUN and Cheong Yooseok. (2011). Physician-industry Relationships in Continuing Medical Education. Korean Journal of Medical Ethics , 14(3), 335-342.
PARK JAE HYUN and Cheong Yooseok. 2011, "Physician-industry Relationships in Continuing Medical Education", Korean Journal of Medical Ethics , vol.14, no.3 pp.335-342. Available from: doi:10.35301/ksme.2011.14.3.335
PARK JAE HYUN, Cheong Yooseok "Physician-industry Relationships in Continuing Medical Education" Korean Journal of Medical Ethics 14.3 pp.335-342 (2011) : 335.
PARK JAE HYUN, Cheong Yooseok. Physician-industry Relationships in Continuing Medical Education. 2011; 14(3), 335-342. Available from: doi:10.35301/ksme.2011.14.3.335
PARK JAE HYUN and Cheong Yooseok. "Physician-industry Relationships in Continuing Medical Education" Korean Journal of Medical Ethics 14, no.3 (2011) : 335-342.doi: 10.35301/ksme.2011.14.3.335
PARK JAE HYUN; Cheong Yooseok. Physician-industry Relationships in Continuing Medical Education. Korean Journal of Medical Ethics , 14(3), 335-342. doi: 10.35301/ksme.2011.14.3.335
PARK JAE HYUN; Cheong Yooseok. Physician-industry Relationships in Continuing Medical Education. Korean Journal of Medical Ethics . 2011; 14(3) 335-342. doi: 10.35301/ksme.2011.14.3.335
PARK JAE HYUN, Cheong Yooseok. Physician-industry Relationships in Continuing Medical Education. 2011; 14(3), 335-342. Available from: doi:10.35301/ksme.2011.14.3.335
PARK JAE HYUN and Cheong Yooseok. "Physician-industry Relationships in Continuing Medical Education" Korean Journal of Medical Ethics 14, no.3 (2011) : 335-342.doi: 10.35301/ksme.2011.14.3.335
2
